Rhythm Pharmaceuticals (RYTM) Leases (2018 - 2025)
Historic Leases for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Q3 2025 value amounting to $3.2 million.
- Rhythm Pharmaceuticals' Leases fell 1198.44% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 1198.44%. This contributed to the annual value of $3.5 million for FY2024, which is 34519.85% up from last year.
- Rhythm Pharmaceuticals' Leases amounted to $3.2 million in Q3 2025, which was down 1198.44% from $3.3 million recorded in Q2 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Leases peaked at $3.7 million during Q2 2024, and registered a low of $670000.0 during Q1 2024.
- Moreover, its 5-year median value for Leases was $1.5 million (2021), whereas its average is $1.9 million.
- In the last 5 years, Rhythm Pharmaceuticals' Leases crashed by 3841.91% in 2024 and then soared by 40253.73% in 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Leases (Quarter) stood at $1.5 million in 2021, then dropped by 22.34% to $1.2 million in 2022, then tumbled by 33.93% to $781000.0 in 2023, then skyrocketed by 345.2% to $3.5 million in 2024, then dropped by 9.17% to $3.2 million in 2025.
- Its Leases stands at $3.2 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.4 million for Q1 2025.